These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sinonasal malignancies with neuroendocrine differentiation: case series and review of literature. Menon S; Pai P; Sengar M; Aggarwal JP; Kane SV Indian J Pathol Microbiol; 2010; 53(1):28-34. PubMed ID: 20090218 [TBL] [Abstract][Full Text] [Related]
4. High-grade sinonasal carcinomas and surveillance of differential expression in immune related transcriptome. Bell D; Bell A; Ferrarotto R; Glisson B; Takahashi Y; Fuller G; Weber R; Hanna E Ann Diagn Pathol; 2020 Dec; 49():151622. PubMed ID: 32927372 [TBL] [Abstract][Full Text] [Related]
5. Identification of novel diagnostic markers for sinonasal undifferentiated carcinoma. Takahashi Y; Gleber-Netto FO; Bell D; Roberts D; Xie TX; Abdelmeguid AS; Pickering C; Myers JN; Hanna EY Head Neck; 2019 Aug; 41(8):2688-2695. PubMed ID: 30932264 [TBL] [Abstract][Full Text] [Related]
6. Sinonasal undifferentiated carcinoma, nasopharyngeal-type undifferentiated carcinoma, and keratinizing and nonkeratinizing squamous cell carcinoma express different cytokeratin patterns. Franchi A; Moroni M; Massi D; Paglierani M; Santucci M Am J Surg Pathol; 2002 Dec; 26(12):1597-604. PubMed ID: 12459626 [TBL] [Abstract][Full Text] [Related]
9. Identification of markers predictive for response to induction chemotherapy in patients with sinonasal undifferentiated carcinoma. Takahashi Y; Gleber-Netto FO; Bell D; Roberts D; Xie TX; Abdelmeguid AS; Pickering C; Myers JN; Hanna EY Oral Oncol; 2019 Oct; 97():56-61. PubMed ID: 31421472 [TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: The importance of differentiation grade in determining treatment strategy. van der Laan TP; Iepsma R; Witjes MJ; van der Laan BF; Plaat BE; Halmos GB Oral Oncol; 2016 Dec; 63():1-9. PubMed ID: 27938993 [TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine Carcinoma and Sinonasal Undifferentiated Carcinoma. Abdelmeguid AS; Bell D; Hanna EY Adv Otorhinolaryngol; 2020; 84():168-184. PubMed ID: 32731236 [TBL] [Abstract][Full Text] [Related]
13. Sex determining region Y-box 2 (SOX2) amplification is an independent indicator of disease recurrence in sinonasal cancer. Schröck A; Göke F; Wagner P; Bode M; Franzen A; Braun M; Huss S; Agaimy A; Ihrler S; Menon R; Kirsten R; Kristiansen G; Bootz F; Lengerke C; Perner S PLoS One; 2013; 8(3):e59201. PubMed ID: 23544055 [TBL] [Abstract][Full Text] [Related]
14. Sinonasal undifferentiated carcinoma: clinicopathological spectrums and diagnosis reappraisal. Vaziri Fard E; Zhang S; Cai Z; Ding J; Sun Q; Saluja K; Zhu H Hum Pathol; 2019 Jul; 89():62-70. PubMed ID: 31054892 [TBL] [Abstract][Full Text] [Related]
15. Multiomics sequencing and immune microenvironment characteristics define three subtypes of small cell neuroendocrine carcinoma of the cervix. Pan B; Yan S; Yuan L; Xiang H; Ju M; Xu S; Jia W; Li J; Zhao Q; Zheng M J Pathol; 2024 Jul; 263(3):372-385. PubMed ID: 38721894 [TBL] [Abstract][Full Text] [Related]
16. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity. Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122 [TBL] [Abstract][Full Text] [Related]